PPA
XERS icon

Parametric Portfolio Associates’s Xeris Biopharma Holdings XERS Stock Holding History

Parametric Portfolio Associates’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$95K Sell
37,212
-27,878
-43% -$68.1K ﹤0.01% 3572
2021
Q4 		$191K Buy
+65,090
New +$141K ﹤0.01% 3435
2021
Q3 		– Sell
-214,286
Closed -$872K – 3670
2021
Q2 		$872K Buy
214,286
+20,281
+10% +$77.4K ﹤0.01% 2831
2021
Q1 		$875K Buy
194,005
+16,174
+9% +$87.2K ﹤0.01% 3224
2020
Q4 		$875K Sell
177,831
-36,032
-17% -$180K ﹤0.01% 3117
2020
Q3 		$1.27M Sell
213,863
-14,609
-6% -$58.4K ﹤0.01% 2772
2020
Q2 		$608K Buy
228,472
+154,598
+209% +$538K ﹤0.01% 3175
2020
Q1 		$144K Sell
73,874
-20,094
-21% -$86.4K ﹤0.01% 3640
2019
Q4 		$662K Buy
93,968
+28,849
+44% +$238K ﹤0.01% 3259
2019
Q3 		$640K Buy
65,119
+10,346
+19% +$116K ﹤0.01% 3246
2019
Q2 		$627K Buy
54,773
+1,434
+3% +$15.1K ﹤0.01% 3272
2019
Q1 		$536K Buy
53,339
+24,577
+85% +$315K ﹤0.01% 3302
2018
Q4 		$489K Sell
28,762
-1,161
-4% -$23.3K ﹤0.01% 3320
2018
Q3 		$526K Buy
29,923
+8,223
+38% +$178K ﹤0.01% 3392
2018
Q2 		$412K Buy
+21,700
New +$422K ﹤0.01% 3420

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's XERS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Xeris Biopharma Holdings (XERS) stake by 43% in Q1 2022, selling an estimated $68.1K and leaving 37,212 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3572.

Parametric Portfolio Associates first reported a position in XERS in Q2 2018 and has held it in 15 quarters since. The position peaked at $1.27M in Q3 2020. 103 funds tracked by Wall St. Rank hold XERS as of Q1 2022.

  • Parametric Portfolio Associates held 37,212 shares of Xeris Biopharma Holdings worth $95K as of Q1 2022.
  • Parametric Portfolio Associates sold 27,878 Xeris Biopharma Holdings shares in Q1 2022, an estimated $68.1K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3572 holding.
  • Parametric Portfolio Associates first reported a position in Xeris Biopharma Holdings in Q2 2018 and has held it in 15 quarters since.
  • Parametric Portfolio Associates's Xeris Biopharma Holdings position peaked at $1.27M in Q3 2020.
  • 103 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.